The African Union (AU) is making good progress in operationalising the African Medicines Agency (AMA), having recently formed its Bureau and currently shaping its governing board. This is according to Chimwemwe Chamdimba, Head of Health at the AU Development Agency (AUDA-NEPAD), who addressed a session of the Africa Health Agenda International Conference (AHAIC) in Rwanda […] Continue reading ->
Africa’s limited pharmaceutical industry, high costs of raw materials, and dependence on imported medicines have long hampered citizens’ access to the medicines they need.  The challenges the continent faces are daunting. They include poor supply chain systems, lack of government investment in the pharmaceutical sector, unfavourable manufacturing conditions, limited health workforce, lack of sustainable health […] Continue reading ->
In a major step forward for the new regulatory alliance, Africa’s third-largest economy, South Africa is now moving to join the African Medicines Agency.  South Africa’s Cabinet has approved the signing of the African Union treaty establishing the African Medicines Agency (AMA) and submitted it to Parliament for ratification, according to a government statement on […] Continue reading ->
African nations need to pivot to prevention in their fight against disease by “addressing its root causes” through a greater focus on improved diets, healthier environments, and better road safety, among other factors, WHO Director-General Dr Tedros Adhanom Ghebreyesus told the 72nd WHO Regional Committee for Africa meeting, at the opening of the weeklong session of […] Continue reading ->
COVID-19 exposed Africa’s vulnerabilities and its urgent need for local innovation and drug development. Leading African scientist KELLY CHIBALE discusses some of the key challenges. Improving scientific skills in Africa and stemming the continent’s brain drain weigh heavily on Professor Kelly Chibale’s mind, particularly as COVID-19 pandemic has damaged fragile health systems and reversed hard-fought […] Continue reading ->
The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading ->